Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzastaurin Plus Temozolomide and Radiation in Newly Diagnosed Glioblastoma
NCT00402116Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2006
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enzastaurin in glioblastoma multiforme (GBM), Gliosarcoma (GS), sponsored by Eli Lilly and Company. Started Sep 2006; status: completed.
02
Drugs
enzastaurin
03
Conditions
glioblastoma multiforme (GBM)Gliosarcoma (GS)
Beyond the preview
Go deeper on NCT00402116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00402116.